Experimental Simulation of the Liver Drug Injury for Investigation of New Hepatoprotectors
Efficient chemotherapy of tuberculosis patients could be complicated by hepatoprotective responses to antituberculosis drugs. The frequency and nature of the response depend on the drug and the genotypical and phenotypical characteristics of its metabolism in the patients, that should be considered...
Saved in:
| Main Authors: | G. N. Mozhokina, N. A. Elistratova, L. P. Mikhaylova, O. V. Makarova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/665 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIMENTAL RATIONALE FOR THE USE OF ROPRENE TO PREVENT ISONIAZID-INDUCED LIVER DAMAGES
by: G. N. Mozhokina, et al.
Published: (2014-07-01) -
EFFECTIVENESS OF ANTHOCYANIN AS A HEPATOPROTECTOR: A SYSTEMATIC LITERATURE REVIEW
by: Khairunnisa Rizqika Amanda Putri, et al.
Published: (2025-01-01) -
MERCHANDISING ANALYSIS OF THE RANGE OF HEPATOPROTECTORS IN PHARMACIES, LERMONTOV
by: K. V. Kabanok, et al.
Published: (2015-09-01) -
Correction of cyclophosphan toxicity by polyphenolic hepatoprotectors
by: A. S. Saratikov, et al.
Published: (2004-03-01) -
Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)